High-risk human papillomavirus E6 inhibits monocyte differentiation to Langerhans cells

26Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

High-risk human papillomaviruses (HPVs) cause a variety of malignancies of the mucosal epithelium. However, the local immune evasion strategies used by HPV-transformed cells remain unclear. Here, we examined the effect of HPV-positive cancer cells on human peripheral blood monocytes, which are precursors of Langerhans cells, key antigen-presenting cells in the squamous epithelium. HPV-positive cervical cancer cells and HPV-E6 expressing cells inhibited monocyte differentiation to Langerhans cells in a contact-dependent manner. Unlike Langerhans cells, monocytes that differentiated in the presence of HPV16 E6-expressing cells exhibited high levels of endocytic activity. Our results suggest that cells infected by high-risk HPV evade immune surveillance by blocking the differentiation of monocytes into competent antigen presenting cells. © 2013 Elsevier Inc.

Cite

CITATION STYLE

APA

Iijima, N., Goodwin, E. C., DiMaio, D., & Iwasaki, A. (2013). High-risk human papillomavirus E6 inhibits monocyte differentiation to Langerhans cells. Virology, 444(1–2), 257–262. https://doi.org/10.1016/j.virol.2013.06.020

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free